| CIC | |
|---|---|
| Gene Symbol | CIC |
| Full Name | Capicua Transcriptional Repressor |
| Chromosomal Location | 19p13.2 |
| NCBI Gene ID | 2055 |
| Ensembl ID | ENSG00000105143 |
| OMIM ID | 607400 |
| UniProt ID | Q96PY5 |
| Associated Diseases | Spinocerebellar Ataxia, Neurodevelopmental Disorders |
| Protein Family | Capicua family (HMG-box transcriptional repressor) |
Cic Capicua Transcriptional Repressor is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Capicua (CIC) is a transcriptional repressor protein that plays critical roles in neuronal development, brain patterning, and synaptic plasticity. It contains an HMG-box DNA-binding domain and a C-terminal repressor domain, functioning as part of the Atx-1/Telent (ATT) transcription factor family. In the nervous system, CIC regulates genes involved in neuronal differentiation, axon guidance, and synaptic formation. Pathogenic variants in CIC are associated with autosomal dominant spinocerebellar ataxia type 2 (SCA2) and neurodevelopmental disorders including intellectual disability and autism spectrum disorder. Recent research suggests CIC dysfunction may contribute to neurodegenerative processes through altered transcriptional regulation of neuronal survival genes.
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
The CIC gene encodes a protein involved in key cellular processes relevant to neuronal function and survival. This protein plays important roles in transcriptional regulation, chromatin dynamics, and cellular signaling pathways that are critical for proper brain function.
Pathogenic variants in CIC are associated with several neurological conditions, including spinocerebellar ataxias, neurodevelopmental disorders, and neurodegenerative diseases. The gene's normal function in transcriptional control and chromatin regulation becomes disrupted in these disease states.
CIC is expressed in various brain regions, with particularly high expression in areas involved in motor control, learning, and memory. The gene shows cell-type specific expression patterns in neurons and glia.
The study of Cic Capicua Transcriptional Repressor has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.